Effects of bethanechol on canine urinary bladder smooth muscle function

Area of Science:

• Pharmacology
• Physiology
• Urology

Background:

• Bethanechol is a muscarinic agonist used to treat urinary retention.
• The precise mechanisms of bethanechol's action and its down-regulatory effects on bladder smooth muscle are not fully understood.

Purpose of the Study:

• To investigate if bethanechol's effects are mediated by muscarinic receptors.
• To determine the role of extracellular calcium in bethanechol-induced bladder contractions.
• To elucidate the mechanisms behind bethanechol's down-regulation of bladder contraction.

Main Methods:

• Isometric force measurements on smooth muscle strips from normal urinary bladders.
• Dose-response studies with bethanechol, acetylcholine (Ach), and potassium chloride (KCl).
• Assessment of contractile responses in the presence of atropine, nifedipine, and calcium-free medium.

Main Results:

• Bethanechol demonstrated a dose-dependent increase in bladder contraction, with higher potency than Ach.
• Contractile responses to bethanechol were significantly reduced by atropine, nifedipine, and calcium-free conditions.
• Pre-treatment with bethanechol diminished KCl-induced contractions but did not affect Ach-induced contractions.

Conclusions:

• Bethanechol activates muscarinic receptors to induce bladder contraction.
• Both intracellular and extracellular calcium are vital for bladder smooth muscle contraction.
• Bethanechol's down-regulatory effect likely involves interference with calcium influx, not receptor desensitization.